Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP710121.RASSk1aElTipp-mgp2jO7pSzHAmxQsRa_g6LDMVIqj4wQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP710121.RASSk1aElTipp-mgp2jO7pSzHAmxQsRa_g6LDMVIqj4wQ130_assertion type Assertion NP710121.RASSk1aElTipp-mgp2jO7pSzHAmxQsRa_g6LDMVIqj4wQ130_head.
- NP710121.RASSk1aElTipp-mgp2jO7pSzHAmxQsRa_g6LDMVIqj4wQ130_assertion description "[These results suggest that CD123 CAR T cells are a promising immunotherapy for the treatment of high-risk AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710121.RASSk1aElTipp-mgp2jO7pSzHAmxQsRa_g6LDMVIqj4wQ130_provenance.
- NP710121.RASSk1aElTipp-mgp2jO7pSzHAmxQsRa_g6LDMVIqj4wQ130_assertion evidence source_evidence_literature NP710121.RASSk1aElTipp-mgp2jO7pSzHAmxQsRa_g6LDMVIqj4wQ130_provenance.
- NP710121.RASSk1aElTipp-mgp2jO7pSzHAmxQsRa_g6LDMVIqj4wQ130_assertion SIO_000772 24030378 NP710121.RASSk1aElTipp-mgp2jO7pSzHAmxQsRa_g6LDMVIqj4wQ130_provenance.
- NP710121.RASSk1aElTipp-mgp2jO7pSzHAmxQsRa_g6LDMVIqj4wQ130_assertion wasDerivedFrom befree-20150227 NP710121.RASSk1aElTipp-mgp2jO7pSzHAmxQsRa_g6LDMVIqj4wQ130_provenance.
- NP710121.RASSk1aElTipp-mgp2jO7pSzHAmxQsRa_g6LDMVIqj4wQ130_assertion wasGeneratedBy ECO_0000203 NP710121.RASSk1aElTipp-mgp2jO7pSzHAmxQsRa_g6LDMVIqj4wQ130_provenance.